Sabashini K Ramchand

10PUBLICATIONS
11CO-AUTHORS
Pharmaceutical delivery technologiesDiscourse and pragmaticsCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Orthodontics and dentofacial orthopaedics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 23, 2025
Comparative bone histomorphometry effects of combined denosumab and teriparatide vs monotherapy in postmenopausal women with osteoporosis: a randomized controlled trial.

Sabashini K Ramchand, Joy N Tsai, Yingshe Zhao

|Oct 04, 2024
Reply to C. Fuchao et al.

Sabashini K Ramchand, Ego Seeman, Rudolf Hoermann

|Jul 30, 2024
Skeletal effects of adjuvant zoledronic acid and its cessation in women with early-stage breast cancer.

Sabashini K Ramchand

|Jul 02, 2024
Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled Trial.

Sabashini K Ramchand, Ali Ghasem-Zadeh, Rudolf Hoermann

|Jan 05, 2024
Cardiometabolic Effects of Denosumab in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression: RCT.

Sabashini K Ramchand, Rudolf Hoermann, Shane White

|Nov 08, 2023
Correction to: The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.

Sabashini K Ramchand, Joy N Tsai, Hang Lee

Pageof 2